A smartphone app could improve breast cancer patients’ adherence to multidisciplinary treatment plans, according to a study published in the Journal of Medical Internet Research.
TOP LINE DATA
A total of 4,475 patients who had received a breast cancer diagnosis and had undergone a discussion about multidisciplinary treatment between March 2013 and May 2019 were included in the study.
They were...
Gainesville, Florida-based etectRx has received FDA 510(k) clearance for its ID-Cap System, a prescription ingestible system that sends adherence event logs to an external medical device.
Similar to the system pioneered by etectRx’s high-profile competitor, Proteus Digital Health, the ID-Cap’s core is a standard capsule containing a sensor that transmits a message once it comes into contact with...
Proteus Digital Health, maker of an ingestible sensor system for treatment adherence monitoring, was forced to furlough many of its employees last month after a $100 million funding round didn’t close as expected, according to a weekend report from CNBC.
These employees were brought back after about two weeks after Proteus was able to secure $5 million in emergency funding, according to the...
AdhereTech’s smart pill bottle platform improved adherence and patient satisfaction among a small sample of multiple myeloma patients, according to a paper in the November issue of the Journal of Managed Care & Specialty Pharmacy.
This data has been roughly four years in the making, and stands the company’s first-ever peer-reviewed publication of adherence efficacy, AdhereTech CEO and...
A new study suggests that Proteus Digital Health’s sensor-embedded pills can improve adherence among Hepatitis C (HCV) patients who are at a high risk for nonadherence.
The data — presented this week at the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting — indicate a 93% overall rate of medication adherence, and a 99.5% rate of sustained virologic response recorded...
AiCure, a nearly decade-old startup using artificial intelligence to measure medication adherence and other behavior during clinical trials or normal care, has brought in $24.5 million in Series C funding.
Palisades Growth Capital led the raise, which also featured new backers Singtel Innov8, Asahi Kasei Corporation, Accelmed Growth Partners, and SpringRock Ventures. The round also included all...
TrialCard, a company that works with pharma manufacturers to link patients to medications and services, announced last week that it is set to acquire Mango Health, maker of a gamified patient engagement tool and medication adherence platform, for an undisclosed amount.
As part of the deal, TrialCard will acquire Mango's app, which lets patients track their medication and adherence. It also has a...
OptimizeRx, a software company focused on pharma-provider digital health messaging, has completed a $9 million deal to acquire medication adherence and care coordination messaging company CareSpeak Communications, OptimizeRx told MobiHealthNews.
With this deal, OptimizeRx will be able to expand its EHR-embedded messaging platform so that phrama and providers can communicate directly with patients...
This morning Wellth, maker of a mobile platform designed to improve treatment adherence through behavioral economics, announced that it scored $5.1 million in seed funding. The round was led by Boehringer Ingelheim’s Venture Fund and NFP’s Venture Fund, with participation from Leonard Schaeffer, CD-Venture, the Partnership Fund for New York City, and Yabeo.
“We are looking forward to working...
Proteus Digital Health’ pitch to track adherence using sensor-equipped pills has found another audience in the HIV prevention community.
Among the featured data presented at this week’s International AIDS Conference in Amsterdam was a trial that outfitted Gilead Sciences’ preventive HIV drug Truvada (tenofovir/emtricitabine) with the tracking technology. Here, researchers found that the sensor-...
